Inhibition of antigen-stimulated effector T cells by human cerebrospinal fluid

NeuroImmunoModulation

Volumn 3, Issue 2-3, 1996, Pages 112-118

  Taylor, Andrew W ^a   Streilein, J Wayne ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Cerebrospinal fluid; Immune privilege; Immunosuppression; Neuroimmunology; T lymphocytes; TGF ; VIP; MSH

Indexed keywords

ALPHA INTERMEDIN; GAMMA INTERFERON; NEUROPEPTIDE; TRANSFORMING GROWTH FACTOR BETA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CEREBROSPINAL FLUID; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; T LYMPHOCYTE;

ALPHA-MSH; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, BACTERIAL; BRAIN; CELL DIVISION; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID PROTEINS; CYTOKINES; HUMANS; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM TUBERCULOSIS; NEUROIMMUNOMODULATION; RABBITS; T-LYMPHOCYTE SUBSETS; TRANSFORMING GROWTH FACTOR BETA; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0029853320     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000097235     Document Type: Article

References (30)

1. Barker CF, Billingham RE: Immunologically privileged sites. Adv Immunol 1977:25:1-54.
2. Medawar P: Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 1948:29:58-69.
3. Raju S, Grogan J: Immunological study of the brain as a privileged site. Transplant Proc 1977:9:1187-1191.
4. Kaplan HJ, Streilein JW: Immune response to immunization via the anterior chamber of the eye. I. Filymphocyte induced-immune deviation. J Immunol 1977;118:809-814.
5. Niederkom J, Streilein JW, Shadduck JA: Deviant immune response to allogeneic tumors injected intracamerally and subculaneouslv in mice. Invest Ophathalmol Vis Sci 1980:20: 355-363.
6. Williamson JSP, Streilein JW: Impaired induction of delayed hypersensitivity following anterior chamber inoculation of alloantigens. Reg Immunol 1988; 1:15-23.
7. Streilein JW: Anterior chamber associated immune deviation: the privilege of immunity in the eye. Surv Ophthalmol 1990:35:67-73.
8. Wilbanks GA, Streilein JW: Distinctive humoral responses following anterior chamber and intravenous administration of soluble antigens. Evidence for active suppression of lgG2a-secrcting B-cells. Immunology 1990:71:566-572.
9. Harling-Berg C, Knopf P, Cserr H: Myelin basic protein infused into cerebrospinal fluid suppresses experimental autoimmune encephalomyelitis. J Neuroimmunol 1991:35:45-51.
10. Streilein JW: Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. Curr Opin Immunol 1993;5:428-432.
11. Gehrmann J, Banati RB, Kreutzberg GW: Microglia in the immune surveillance of the brain. Human microglia constitutivcly express HLA-DR molecules. J Neuroimmunol 1993:48:189-198.
12. Bradbury M: The structure and function of the blood-brain barrier. Fed Proc 1984:43:186-190.
13. Thompson E: Differences in CSF versus serum proteins; in Thompson E (eds): The CSF proteins: a Biochemical Approach. Oxford, Elsevier, 1988, pp 27-34.
14. Cserr HF, Knopf PM: Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol Today 1992; 13:507-512.
15. Cserr H: Physiology of the choroid plexus. Physiol Rev 1971:51:273-311.
16. Hickey W, Hsu B, Kimura H: T-lymphocyte entry into the central nervous system. J Neu-rosci Res 1991;28:254-260.
17. Wilbanks G, Streilein J: Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-p. Eur J Immunol 1992:22: 1031-1036.
18. Streilein JW, Wilbanks GA, Taylor AW, Cousins S: Eye-derived cytokines-and the immunosuppressive intraocular microenvironment: A review. Curr Eye Res 1992; 11:(suppl):41-47.
19. Lawrence DA: Identification and activation of latent transforming growth factor p. Methods Enzymol 1991;198:327-336.
20. Taylor A, Streilein J. Cousins S: Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res 1992; 11:1199-1206.
21. Taylor AW, Streilein JW, Cousins SW: Immu-noreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J Immunol 1994; 153: 1080-1086.
22. Cousins SW, McCabe MM, Danielpour D, Streilein JW: Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol VisSci 1991;32:33-43.
23. Granstein R, Staszcwski R, Kniscly TL, Zeira E, Nazareno R, Latina M, Albert DM: Aqueous humor contains transforming growth factor-β and a small (3500 daltons) inhibitor of thymocyte proliferation. J Immunol 1990; 144: 3021-3026.
24. Kaiser CJ, Ksander BR, Streilein JW: Inhibition of lymphocyte proliferation by aqueous humor. Reg Immunol 1989;2:42-49.
25. Taylor AW: Immunorcgulation of the ocular effector responses by soluble factors in aqueous humor. Reg Immunol 1994;6:52-57.
26. Jampel HD, Roche N, Stark WJ, Roberts AB: Transforming growth factor-P in human aqueous humor. Curr Eye Res 1990:9:963-969.
27. Wilbanks GA, Streilein JW: Macrophages capable of inducing anterior chamber associated immune deviation demonstrate spleen-seeking migratory properties. Reg Immunol 1992;4: 130-137.
28. Annie T, Fong T, Mosmann TR: The role of INF-y in deiayed-type hypersensitivity mediated by ThI clones. J Immunol 1989; 143: 2887-2893.
29. Taylor AW, Streilein JW, Cousins SW: A-Mela-nocyte-stimulating hormone suppresses antigen-stimulated T cell production of gamma-interferon. Neuroimmunomodulation 1994; 1: 188-194.
30. Wakefield LM, Smith DM, Flanders KC, Spom MB: Latent transforming growth factor-13 a high molecular weight complex containing precursor sequences. J Biol Chem 1988;263: 7646-7654.